The impact of membrane selection on quality assurance in dialysis

  • Lee W. Henderson
Part of the Developments in Nephrology book series (DINE, volume 39)


Broadly considered, the selection of a membrane for treatment of the patient with kidney failure determines whether transplantation (glomerular basement membrane), peritoneal dialysis or treatment with the artificial kidney occurs. I will narrow the topic by excluding kidney transplantation but will explore the various options within the latter two modes of treatment. I recognize, however, that receipt and retention of a good quality kidney graft offers the best duration and quality of life and must be considered as the gold standard against which all other modes of treatment must be judged.


Peritoneal Dialysis Total Body Water Residual Renal Function Uremic Toxin Peritoneal Membrane 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    National Cooperative Dialysis Study. Kidney Int 1983; 23(13).Google Scholar
  2. 2.
    Held PJ, Brunner F, Odaka M, Garcia J, Port FK and Gaylin DS. Five year survival for end stage renal disease patients in the U.S., Europe and Japan, 1982–1987. Am J Kidney Dis 1990; 15:451–7.PubMedGoogle Scholar
  3. 3.
    Hull AR and Parker TF, editors Proceedings from the morbidity, mortality and prescription of dialysis symposium, Sept 15–17, 1989, Dallas. Am J Kidney Dis 1990;15:5.Google Scholar
  4. 4.
    Gotch FA and Sargent JA. A mechanistic analysis of the National Cooperative Dialysis Study. Kidney Int 1985; 28:526–34.PubMedCrossRefGoogle Scholar
  5. 5.
    DOQI Clinical Practice Guidelines. Am J Kidney Dis 1997; 30:3(2).Google Scholar
  6. 6.
    Henderson LW, Leypoldt JK, Lysaght MJ and Cheung AK. Death on dialysis and the time/flux trade-off. Blood Purif 1997; 15:1–14.Google Scholar
  7. 7.
    Henderson LW. Selection of transport parameters in judging membrane performance. In Henderson LW and Thuma RS, editors. Quality assurance in dialysis, vol 2. Dordrecht, Kluwer Academic Publishers, 1998; 20.Google Scholar
  8. 8.
    Churchill DN, Taylor W and Keshaviah PR. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol 1996; 7:198–207.Google Scholar
  9. 9.
    Johnson WJ, Hagge WW, Wagoner RD, Dinapoli RP and Rosevear JW. Effects of urea loading in patients with far advanced renal failure. Mayo Clinic Proc 1972; 47:21–9.Google Scholar
  10. 10.
    Gorevic PD, Casey TT, Stone WJ, DiRiaimondo CR, Presli FC and Fragione B. Beta-2 microglobulin is an amyloidogenic protein in man. J Clin Invest 1985; 76:2425–9.PubMedGoogle Scholar
  11. 11.
    Hörl WH, Haag-Weber M, Georgopoulos A and Block LH. Physicochemical characterization of a polypeptide present in uremic serum that inhibits the activity of polymorphonuclear cells. Proc Natl Acad Sci 1990; 87:6353–7.PubMedCrossRefGoogle Scholar
  12. 12.
    Bergstrom J, Furst P and Zimmerman L. Uremic middle molecules exist and are biologically active. Clin Nephrol 1979; 11:229–38.PubMedGoogle Scholar
  13. 13.
    Henderson LW. Of time, TACurea and treatment schedules. Kidney Int 1988; 24: S105–6.Google Scholar
  14. 14.
    Leypoldt JK, Cheung AK, Carroll CE, Stannard D, Pereira B, Agadoa L et al. Removal of middle molecules enhances survival in hemodialysis (HD) patients. Am J Kid Dis (in press).Google Scholar
  15. 15.
    Frost TH and Kerr DNS. Kinetics of hemodialysis: a theoretical study of the removal of solutes in chronic renal failure compared to normal health. Kidney Int 1977; 12:41–50.PubMedCrossRefGoogle Scholar
  16. 16.
    Miller JH, von Albertini B, Gardiner PW and Shinaberger JH. Technical aspects of high-flux hemodiafiltration for adequate short (under 2 hours) treatment. Trans Am Soc for Art Int Organs 1984; 30:377–81.Google Scholar
  17. 17.
    Laird NM, Berkey CS and Lowrie EG. Modeling success or failure of dialysis therapy: The National Cooperative Dialysis Study. Kidney Int 1983; 13:S101–6.Google Scholar
  18. 18.
    Lowrie EG and Lew NL. Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death-rate differences betwen facilities. Am J Kidney Dis 1990; 15:458–82.PubMedGoogle Scholar
  19. 19.
    Held PJ, Levin NW, Bovbjerg RR, Pauly MV and Diamond LH. Mortality and duration of hemodialysis treatment. JAMA 1992; 265:871–5.CrossRefGoogle Scholar
  20. 20.
    Held PJ, Blagg CR, Liska DW, Port FK, Hakim R and Levin N. The dose of hemodialysis according to dialysis prescription in Europe and the United States. Kidney Int 1992; 42:S16–21.Google Scholar
  21. 21.
    Anderstam B, Mamoun A-H, Södersten P and Bergström J. Middle-sized molecule fractions isolated from uremic ultrafiltrate and normal urine inhibit ingestive behavior in the rat. J Am Soc Nephrol 1996; 7:2453–60.PubMedGoogle Scholar
  22. 22.
    Shinzato T, Nakai S, Akiba T, Yamazaki C, Sasaki R, Kitaoka T et al. Survival in long-term haemodialysis patients: results from the annual survey of the Japenese Society for Dialysis Therapy. Nephrol Dial Transplant 1997; 12:885–8.Google Scholar
  23. 23.
    Maeda et al. Personal communication 1997.Google Scholar
  24. 24.
    Babb AL, Popovich RP, Christopher TG and Scribner BH. The genesis of the square meter hour hypothesis. Trans Am Soc for Artif Int Organs 1971; 17:81–91.Google Scholar
  25. 25.
    Henderson LW and Clark W. Modeling and the middle molecule. Semin Dial 1998; 11:228–30.Google Scholar
  26. 26.
    Teehan BP, Schleifer CR, Brown JM, Sigler MH and Raimondo J. Urea Kinetic analysis and clinical outcome on CAPD. A five year longitudinal study. Adv in PD 1990; 6:181–5.Google Scholar
  27. 27.
    Lindsay RM and Spanner E. A hypothesis: the protein catabolic rate is dependent upon the type and amount of treatment in dialyzed uremic patients. Am J Kidney Dis 1989; 13:382–9.PubMedGoogle Scholar
  28. 28.
    Lindsay RM, Spanner E, Heidenheim RP, LeFebvre JM, Hodsman A, Baird J et al. Which comes first Kt/Vor PCR — chicken or egg. Kidney Int 1992; 42:S32–6.Google Scholar
  29. 29.
    Young A, Kopple J, Lindholm G, Vonesh E et al. Nutritional assessment of CAPD patients: an international study. Am J Kidney Dis 1991; 17:462–71.PubMedGoogle Scholar
  30. 30.
    Held PJ, Port FK, Gaylin DS, Wolfe RA, Levin NW, Blagg CR et al. Evaluation of initial predictors of mortality among 4387 new ESRD patients: the USRDS case mix study, (abstract) JASN 1991; 2:328.Google Scholar
  31. 31.
    Considine RV, Beckie M, Dunn SR, Weisberg LS, Brenda RC, Kurnik P et al. Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients. Kidney Int 1997; 51:1980–5.PubMedCrossRefGoogle Scholar
  32. 32.
    Coyne E, Marabet S, Dagogo-Jack S, Klein S, Santiago JV, Hmiel SP et al. Increased leptin concentration in hemodialysis (HD) patients (abstract) JASN 1996; A1908.Google Scholar
  33. 33.
    Sharma K, Michael B, Dunn S, Weisberg L, Kurnik B, Kurnik P et al. Plasma leptin is cleared by the kidney and is markedly elevated in hemodialysis patients, (abstract) JASN 1996; A3085.Google Scholar
  34. 34.
    Collins A, Liao M, Umen A, Hanson G and Keshaviah P. High efficiency bicarbonate hemodialysis has a lower risk of death in standard acetate dialysis. J Am Soc Nephrol 1991; 2:318.Google Scholar
  35. 35.
    Collins A, Liao M, Umen A, Hanson G and Keshaviah P. Diabetic hemodialysis patients treated with a high Kt/V have a lower risk of death than standard Kt/V. J Am Soc Nephrol 1991; 2:318.Google Scholar
  36. 36.
    Clark WR, Leypoldt JK, Henderson LW, Sowinski KM, Scott MK, Mueller BA et al. Effect of changes in dialytic frequency duration and flow rates on solute kinetics and effective clearances. JASN 1998; in press.Google Scholar
  37. 37.
    Channard J, Brunois JP, Melin JP, Lavaud S and Toupance O. Long term results of dialysis therapy with a highly permeable membrane. Artif Organs 1982; 6:261–6.CrossRefGoogle Scholar
  38. 38.
    von Albertini B, Barlee V and Bosch JP. High flux hemodialfiltration: Long term results, (abstract). J Am Soc Nephrol 1991; 2:354.Google Scholar
  39. 39.
    Cheung AC, Kato Y, Leypoldt JK and Henderson LW. Hemodiafiltration using a hybrid membrane system for self-generation of diluting fluid. Trans Am Soc for Art Int Organs 1982; 28:61–5.Google Scholar
  40. 40.
    von Albertini B. High-efficiency hemodialysis: an overview. Contrib to Nephrology 1988; 61:37–45.Google Scholar
  41. 41.
    Gutierrez A, Alvestrand A, Wahren J and Bergstrom J. Effective in vivo contact between blood and dialysis membranes on protein catabolism in humans. Kidney Int 1990; 38:487–94.PubMedCrossRefGoogle Scholar
  42. 42.
    Gutierrez A, Alvestrand A and Bergstrom J. Membrane selection and muscle protein catabolism. Kidney Int 1992; 42:S86–90.Google Scholar
  43. 43.
    Borah MF, Shoenfeld P, Gotch FA, Sargent JA, Wolfsom M and Humphreys MH. Nitrogen balance during intermittent dialysis therapy of uremia. Kidney Int 1978; 14:491–500.PubMedCrossRefGoogle Scholar
  44. 44.
    Farrell PC and Hone PW. Dialysis induced catabolism. Am J Clin Nutr 1980; 33:1417–22.PubMedGoogle Scholar
  45. 45.
    Quellhorst E. Long-term survival. In Henderson LW, Quelhorst EA, Baldamus CA and Lysaght MJ, editors. Hemofiltration. Berlin, Springer-Verlag, 1986; 221.Google Scholar
  46. 46.
    Rippe B and Stelin G. Simulations of peritoneal solute transport during CAPD. Application of the two-pore formalism. Kidney Int 1989; 35:1234–44.PubMedCrossRefGoogle Scholar
  47. 47.
    Nolph KD and Twardowski Z. The peritoneal dialysis system. In Nolph KD, editor. Peritoneal dialysis, 3rd edition. Dordrecht, Kluwer Academic Publishers, 1989; 13–27.Google Scholar
  48. 48.
    Dedrick RL, Flessner MF, Collins JM and Schultz JS. Is the peritoneum a membrane? Am Soc Artif Ini Organs 1982; 5:1–8.Google Scholar
  49. 49.
    Pannekeet MM, Mulder JB, Weening JJ, Struijk DG, Zweers MM and Krediet RT. Demonstration of aquaporin-chip in peritoneal tissue of uremic and CAPD patients. Proceedings VIIth Congress ISPD, June 18–21, Stockholm. Perit Dial Bull 1995; 16:S54–57.Google Scholar
  50. 50.
    Henderson LW. The problem of peritoneal area and permeability. Kidney Int 1973; 3:409–10.PubMedCrossRefGoogle Scholar
  51. 51.
    Babb AL, Johansen PJ, Strand MJ, Tenckhoff H and Scribner BH. Bi-directional permeability of the human peritoneum to middle molecules. Proceedings of the European Dialysis and Transplantation Association 1973; 10:247–62.Google Scholar
  52. 52.
    Henderson LW. Why do we use clearance. Blood Purif 1995; 13:283–8.PubMedCrossRefGoogle Scholar
  53. 53.
    Henderson LW and Nolph KD. Altered permeability of the peritoneal membrane after using hypertonic peritoneal dialysis fluid. J Clin Invest 1969; 48:992–1001.PubMedGoogle Scholar
  54. 54.
    Keshaviah P. Urea kinetic and middle molecule approaches to assessing the adequacy of hemodialysis and CAPD. Kidney Int 1992; 43:S28–38.Google Scholar
  55. 55.
    Keshaviah PR, Nolph KD and VanStone JC. The peak concentration hypothesis: a urea kinetic approach to comparing the adequacy of continuous ambulatory peritoneal dialysis and hemodialysis. Perit Dial Bull 1989; 9:257–60.Google Scholar
  56. 56.
    Bergstrom J, Alvestrand B, Lindholm B, and Tranaeus A. Relationship between Kt/V and protein catabolic rate (PCR) is different in continuous peritoneal dialysis (CPD) and haemodialysis (HD) patients. JASN 1991; 2:358 (abstract).Google Scholar
  57. 57.
    Lysaght MJ, Vonesh E, Gotch F, Ibels L, Keen M, Lindholm B et al. The influence of dialysis treatment modality on the decline of remaining renal function. Trans Am Soc Artif Intern Organs 1991; 27:598–604.Google Scholar
  58. 58.
    Wolf AV, Remp DG, Kiley JE and Currie GD. Artificial kidney function: kinetics of hemodialysis. J Clin Invest 1951; 30:1062–70.PubMedCrossRefGoogle Scholar
  59. 59.
    Smith HW. Principles of renal physiology. New York. Oxford University Press, 1956; 25 35.Google Scholar
  60. 60.
    Keshaviah PR and Star RA. A new approach to diaysis quantification: an adequacy index based on solute removal. Semin Dial 1994; 7:85–90.Google Scholar
  61. 61.
    Villano R and Amin N. Assigning severity indices to outcome. Quality Assurance in Dialysis, vol 2, 1998.Google Scholar

Copyright information

© Kiuwer Academic Publishers 1999

Authors and Affiliations

  • Lee W. Henderson

There are no affiliations available

Personalised recommendations